← back to search

Kandai Nozu

Kobe Children's Hospital · JP
Area of research
Nephrology · Molecular Biology
Research interest
Research interests include Renal Diseases and Glomerulopathies, Renal and related cancers, Cell Adhesion Molecules Research, and Ion Transport and Channel Regulation.
h-index
48
citations
9,211
works
570
NIH funding
primary concept
email

Recent publications

A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants
Kidney International 2023cited by 30position: middledoi
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
Pediatric Nephrology 2022cited by 247position: middledoi
Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2022cited by 180position: middledoi
Effects of Bardoxolone Methyl in Alport Syndrome
Clinical Journal of the American Society of Nephrology 2022cited by 46position: middledoi
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
American Journal of Nephrology 2021cited by 47position: middledoi
Biallelic variants in <i>LIG3</i> cause a novel mitochondrial neurogastrointestinal encephalomyopathy
Brain 2021cited by 41position: middledoi
Clinical trial recommendations for potential Alport syndrome therapies
Kidney International 2020cited by 14position: middledoi
Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment
Nature Communications 2018cited by 124position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Arlene B. Chapman · Deakin University2 papers (2021–2022)Roser Torrá · Hospital de Sant Pau2 papers (2021–2022)Bertrand Knebelmann · Hôpital Necker-Enfants Malades2 papers (2021–2022)Bradley A. Warady · Mercy Research2 papers (2021–2022)Angie Goldsberry · Reata Pharmaceuticals (United States)2 papers (2021–2022)Glenn M. Chertow · Center for Clinical Research (United States)2 papers (2021–2022)Kazumoto Iijima · Kobe Children's Hospital2 papers (2021–2022)Peter Stenvinkel · Karolinska University Hospital2 papers (2021–2022)Pablo E. Pérgola · Renal Associates P. A.2 papers (2021–2022)Melanie Chin · BioClinica (United States)2 papers (2021–2022)Arnold L. Silva · Boise Kidney & Hypertension Institute2 papers (2021–2022)Lesley A. Inker · Boston University2 papers (2021–2022)Sripal Bangalore · Hinge Health2 papers (2021–2022)Geoffrey A. Block · Renal Associates P. A.2 papers (2021–2022)Colin J. Meyer · Reata Pharmaceuticals (United States)2 papers (2021–2022)Megan O’Grady · Universitat Autònoma de Barcelona2 papers (2021–2022)Gerald B. Appel · NewYork–Presbyterian Hospital2 papers (2021–2022)Keisha L. Gibson · University of North Carolina at Chapel Hill2 papers (2021–2022)Sharon Andreoli · Riley Hospital for Children2 papers (2021–2022)Michelle N. Rheault · University of Minnesota, Twin Cities1 papers (2022–2022)